2013

RENCARE was established

2014

Obtained 12 Patents for Holter ECG series issued by the State Intellectual Property Office of the People’s Republic of China

2015

Obtained 4 software copyrights Patents & 12 Patents for ECG series issued by the State Intellectual Property Office of the People’s Republic of China

Obtained ISO13485 (TUV) Certificate for Medical Device

Obtained CE certificate for Holter ECG and Patient monitors

RENCARE Trademark registration was approved

Obtained CFDA certificate for Holter ECG series

Obtained the Shenzhen Science and Technology Innovation Commission Entrepreneurial Funding Project: Wireless Remote Wearable ECG Real-time Monitoring and Analysis System

2016

Release iHolter series (i3/12; i3/12plus)

Release PCECG workstation

Obtained certificate of software copyrights patents for Might-net network system & analysis software

Obtained CE certificate & CFDA for Holter ECG (iHolter series), Might-net software & PCECG workstation

2017

Obtained investment from the listed company Lifescience ( Stock: 300506)

Launched development of  4G Holter, Wireless/Bluetooth

Release 12/15/18 Channel ECG machine, Bluetooth Single channel Holter ECG (Mi-Rhythm)

Obtained CE certificate & CFDA for ECG machine & Mi-Rhythm

Awarded the title of "National High-tech Enterprise Certification" & "Shenzhen Enterprise Innovation Record"

2018

Obtain SFDA certificate of 4G real-time Holter ECG

Awarded "Shenzhen Enterprise Innovation Record" again

Remote ECG network project served more than 1,000 primary hospitals, with an annual data volume of more than 200,000 cases

2019

Release Bluetooth ECG workstation

2020

Release Portable ECG machine

2021

Participated in the research and development of the "Intelligent Wearable Cardiopulmonary Signal Detector" project invested by the Bio-Island Laboratory with a research and development fund of 19.81 million yuan.